DIN 02390183 — ACT EXEMESTANE 25 MG
ACT EXEMESTANE is a tablet of Exemestane marketed by TEVA CANADA LIMITED. The full Exemestane monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02390183
- Brand name
- ACT EXEMESTANE
- Active ingredient
- Exemestane
- Strength
- 25 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Steroidal aromatase inactivator (hormonal antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Exemestane products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02419726 | APO-EXEMESTANE | 25 MG | TABLET | APOTEX INC | DORMANT |
| 02242705 | AROMASIN | 25 MG | TABLET | PFIZER CANADA ULC | MARKETED |
| 02407841 | MED-EXEMESTANE | 25 MG | TABLET | GENERIC MEDICAL PARTNERS INC | MARKETED |